Dr Reddys Laboratories (RDY) Treasury Shares (2018 - 2026)

Dr Reddys Laboratories' Treasury Shares history runs 9 years deep, the most recent figure standing at $19.9 million for Q1 2026.

• In Q1 2026, Treasury Shares fell 24.06% year-over-year to $19.9 million; the TTM figure through Mar 2026 stood at $19.9 million (down 24.06% YoY), while the FY2026 annual figure was $19.0 million, down 29.63% from the prior year.
• Treasury Shares was $19.9 million for Q1 2026 at Dr Reddys Laboratories, up from -$22.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $26.1 million in Q1 2025 to a low of -$22.2 million in Q3 2025.
• Historically, Treasury Shares has averaged $3.3 million across 5 years, with a median of $11.9 million in 2024.
• Biggest YoY gain for Treasury Shares was 119.09% in 2025; the steepest drop was 103.28% in 2025.
• A 5-year view of Treasury Shares shows it stood at -$19.2 million in 2022, then jumped by 35.77% to -$12.4 million in 2023, then climbed by 11.55% to -$10.9 million in 2024, then tumbled by 103.28% to -$22.2 million in 2025, then surged by 189.41% to $19.9 million in 2026.
• The last three Treasury Shares figures came in at $19.9 million (Q1 2026), -$22.2 million (Q3 2025), and $26.1 million (Q1 2025), per Business Quant data.